"We are on the verge of a revolution in medicine: understanding, treating, and ultimately preventing the causes of degenerative aging. But medical revolutions only happen if we all stand up in support of funding and research. We did it for cancer. We're doing it for Alzheimer's. We can do it for aging - and create an era of longer, healthier lives!"

Required Reading
Activism and Advocacy
Calorie Restriction
The Community, Visualized
Cryonics
Healthy Life Extension Explained
Introductory Articles
Longevity Meme Newsletter
Methuselah Foundation
Mprize for Longevity Research
Stem Cells, Regenerative Medicine
SENS, Negligible Senescence
What is Anti-Aging?

On the Causes of Aging
Accumulating AGEs
The Failing Immune System
Junk in the Lysosome
Mitochondrial Free Radicals
Senescent Cells
Other Causes of Aging

Objections Answered
Boredom
Inequality and Economics
Overpopulation
Stagnation
The Tithonus Error
What About Retirement?

Recent Entries

  • Graying Hair and Fading Stem Cells
  • Calorie Restriction and DNA Damage
  • The Methuselah Gene, Examined
  • Calorie Restriction Protects Against Age-Related Muscle Loss
  • The Things You Can Change
  • Reminder: Aging 2008 on June 27th at UCLA
  • Ageless Animals, the Sea Urchin Edition
  • Aging
  • 500 Scientists
  • Horizons For Immunotherapy
  • Revisiting Sirtuins
  • Complicating WILT
  • Aging as a Challenge For Regenerative Medicine
  • More On Telomere Shortening and Mitochondrial Dysfunction
  • Signs of Rose-Type Immortality in Humans?
  • Next Steps For Longevity Science at the Methuselah Foundation
  • Updates at Ouroboros
  • Why Do We Accumulate Senescent Cells Anyway?
  • The Immune Response Connection to Alzheimer's Disease
  • The Million Year Lifespan

    Weblogs of Interest
    Accelerating Future
    Ageing Research
    Alcor News
    Al Fin Longevity
    April's CR Diary
    Andart
    Anti-Aging Medicine & Science
    Biosingularity
    CRON Diary
    Cryonics Society
    Depressed Metabolism
    Digital Crusader
    Distributed Republic
    Ethical Technology Blog
    Existence is Wonderful
    Frontier Channel
    Future Current
    FuturePundit
    grailsearch.org
    Longevity Science
    Marginal Revolution
    Metamagician and the Hellfire Club
    Methuselah Foundation Blog
    Mises Economics Blog
    Nanodot
    Ouroboros
    Overcoming Bias
    Pimm - Partial immortalization
    Responsible Nanotechnology
    ScienceBlogs
    Sentient Developments
    Singularity Institute Blog
    The Loom
    The Speculist
    Tangled Bank
    Transumanar

      
    Search

    Archives (Monthly)

    June 2008
    May 2008
    April 2008
    March 2008
    February 2008
    January 2008
    December 2007
    November 2007
    October 2007
    September 2007
    August 2007
    July 2007
    June 2007
    May 2007
    April 2007
    March 2007
    February 2007
    January 2007
    December 2006
    November 2006
    October 2006
    September 2006
    August 2006
    July 2006
    June 2006
    May 2006
    April 2006
    March 2006
    February 2006
    January 2006
    December 2005
    November 2005
    October 2005
    September 2005
    August 2005
    July 2005
    June 2005
    May 2005
    April 2005
    March 2005
    February 2005
    January 2005
    December 2004
    November 2004
    October 2004
    September 2004
    August 2004
    July 2004
    June 2004
    May 2004
    April 2004
    March 2004
    February 2004
    January 2004

    Creative Commons License
    Attribution, noncommercial, no derivative works. Play nice.

  • « A View of DNA Damage and Aging | Main | The Challenges Inherent In Structuring a Cryonics Provider »

    Friday, January 18, 2008

    Tontines: Not a Smart Idea In An Era of Biotechnology

    There have been repeated rumblings on the topic of longevity insurance in the past few years:

    Here is a knee-jerk response: unless these products are stunningly bad value for money under very conservative estimates for growth in life expectancy in the old, those companies to offer longevity insurance packages will be taking a bath twenty to thirty years from now. You might recall that the actuaries are wavering on their estimates for life expectancy, and a healthy debate is taking place in the actuarial community as to just how to account for the ongoing revolution in biotechnology and medicine. An insurer that offers fair valued, competitive products today based on the actuarial trends of the past few years will find themselves in trouble down the line if the efforts of groups like the Methuselah Foundation succeed, or even if the systems biologists have their more modest way.

    In general, betting against increasing longevity seems to be a fool's game. But even the venerable tontine is making a comeback as the vast - and consequently archly conservative - insurance industry grapples in slow motion with uncertainty brought on by radical change and progress in biotechnology and aging science:

    If you die earlier than your scheme's age range, your family receives your original lump sum without any investment gains. But if you live, you will be paid an income which goes up every year depending initially on your investment growth - this is offshore in Ireland so tax is minimised - but also on how many others in the plan die.

    The clever part, according to the company, is the so-called "birthday units" - although "deathday units" would be more accurate, as survivors get a regular investment boost from the funds of plan holders who die. Helped by the death of others, a man on an 80 to 100 plan with £50,000 originally invested would get £19,600 a year at 80, rising to £30,600 at 90 and increasing to £257,000 a year 10 years later when he reaches 100. But do its figures stack up? And is it the only solution? "It sounds like a tontine to me," says retirement income expert Nigel Callaghan at Hargreaves Lansdown. A tontine is an old-fashioned form of life insurance where everyone pays in but the last one living scoops the pool.

    Looking at the Wikipedia entry for "tontine", I note:

    Tontines were the first government bonds issued anywhere in the world, and the British government first issued tontines in 1693 to fund a war against France. However, tontines soon caused problems for their issuing governments, as they would increasingly underestimate the longevity of the population.

    Sound familiar? The monolithic, regulated insurance industry of today, faced with the potential of true rejuvenation medicine in the next few decades, isn't looking much better than 17th century governments. It just isn't smart to bet against healthy longevity in the midst of revolution in biotechnology. A great many people will wind up losing their shirts - make sure you aren't one of them.

    Posted by Reason at January 18, 2008 9:24 PM | TrackBack (0)

    Post a comment; thoughtful, considered opinions are valued. Please note that comments incorporating ad hominem attacks, advertising and other forms of inappropriate behavior are likely to be deleted.










    Remember personal info?